Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Axion BioSystems, a leading life sciences tools company focused on cutting-edge live-cell bioelectronic assay and imaging ...

The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

According to MarketsandMarkets™, the Drug Discovery Technologies Market is projected to grow from about USD 30.58 billion in ...

High-throughput mass spectrometry (HT-MS) has emerged as an indispensable tool in drug discovery, offering rapid, sensitive and label‐free detection of biochemical transformations. By coupling ...

Artificial intelligence (AI) is transforming the life sciences industry, with potentially its most significant impact on drug ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

Laboratories turned to a smart workaround when COVID‑19 testing kits became scarce in 2020. They mixed samples from several ...